How it works
Built for the clinical reality
of African healthcare
KEMIRIX checks every prescription against drug databases, organ function, patient genetics, and traditional medicine use — and tells the clinician exactly what to do, before anything reaches the patient.
Request Early AccessThe process
Three steps. One clear answer.
Enter the patient's prescriptions
A doctor, pharmacist, or nurse enters the current medications, lab values like kidney function, and any traditional remedies the patient is using.
KEMIRIX runs a full safety check
The engine cross-checks everything simultaneously — drug combinations, organ function thresholds, genetic metabolism factors, and traditional medicine conflicts. In real time.
The clinician gets a clear report
Not a wall of text. A structured output: what's dangerous, why, what the evidence says, and what to do next. Referenced. Actionable. Plain language.
What KEMIRIX checks
Six safety modules, running at once
Every patient query runs through all six simultaneously. Nothing gets skipped.
Drug-Drug Interaction
Every medication is checked against every other. If two drugs clash — pharmacodynamically or pharmacokinetically — KEMIRIX flags it, grades the severity, and tells the clinician exactly what to do instead.
Organ Function Safety
When a patient's kidneys or liver aren't working properly, standard doses can become dangerous. KEMIRIX uses eGFR and hepatic scores to adjust recommendations automatically.
Pharmacogenomics
Genetics affect how people process drugs. KEMIRIX screens for African-population genetic variants that most systems ignore — CYP2D6, CYP2C19, G6PD, HLA, and more — aligned to CPIC guidelines.
Traditional Medicine
Patients across Africa use traditional herbs alongside their prescriptions. KEMIRIX is the first platform to screen for these interactions at clinical scale — something no other CDS tool does.
Hard Contraindications
Some combinations are never acceptable. For these, KEMIRIX issues an immediate block — not a suggestion, not a warning. A stop. The clinician must acknowledge it before proceeding.
Clinical Reports
Every analysis produces a structured report: what was found, why it matters, what the evidence says, and what to do next. Plain language. Referenced. Actionable.
Where the data comes from
Licensed, peer-reviewed sources
Every recommendation traces back to a verified clinical database. No generated content, no guesswork.
Licensed drug interaction and adverse reaction database
Pharmacogenomics knowledge base and variant annotations
Clinical pharmacogenomics implementation consortium guidelines
US FDA adverse event reports and drug safety data
WHO anatomical therapeutic chemical classification
Kenya Standard Treatment Guidelines 2023
Security & compliance
Built to the standard healthcare demands
Patient data is protected. Clinical outputs are traceable. Regulators, institutions, and patients can all verify that.
Kenya PPB SaMD Class II
Pursuing certification with Kenya's Pharmacy and Poisons Board — aligned with IMDRF international SaMD frameworks.
ODPC Registered
Compliant with Kenya's Office of the Data Protection Commissioner and the Data Protection Act 2019.
NACOSTI Licensed
Licensed for clinical research operations in Kenya.
AES-256 Encryption
All patient data is encrypted at rest and in transit. Always.
TLS 1.3
Secure transport for all data exchanged between the platform and its users.
Full Audit Logs
Every clinical output, every override, every access — logged and traceable.
Want to see it working?
Request early access and we'll walk you through a live demonstration tailored to your clinical environment.